相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
868612-83-3
- 规格:
10 mM * 1 mL/5 mg/10 mg/25 mg/50 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥935.0 |
|---|---|---|---|
| 规格: | 5 mg | 产品价格: | ¥850.0 |
| 规格: | 10 mg | 产品价格: | ¥1400.0 |
| 规格: | 25 mg | 产品价格: | ¥2900.0 |
| 规格: | 50 mg | 产品价格: | ¥4600.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
IN-1130
CAS No. : 868612-83-3
MCE 国际站:IN-1130
产品活性:N-1130 是一种高度选择性的转化生长因子-β I 型受体激酶 (ALK5) 抑制剂,对 ALK5 介导的 Smad3 磷酸化的 IC50 为 5.3 nM。IN-1130 抑制酪蛋白的 ALK5 磷酸化 (IC50=36 nM),抑制 p38α 丝裂原活化的蛋白激酶 (IC50=4.3 μM)。IN-1130 可抑制阻塞性肾病中的肾纤维化,阻止乳腺癌的肺转移。
研究领域:TGF-beta/Smad
作用靶点:TGF-β Receptor
In Vitro: IN-1130 (0.5, 1 μM; for 2 hours) inhibits TGF-β-stimulated Smad2 phosphorylation and subsequent nuclear translocation in HepG2 and 4T1 cells.
?IN-1130 (1 μM; for 72 hours) restores the TGF-β-mediated decrease in E-cadherin protein expression. IN-1130 (1 μM; for 72 hours) inhibits TGF-β-induced MMPs mRNA expression and the gelatinolytic activity of secreted MMPs in MCF10A cells.
?IN-1130 (1 μM; pretreated for 30 min) inhibits TGF-β-induced MDA-MB-231 cells, NMuMG, and MCF10A cells mobility and invasion.
In Vivo: IN-1130 (10, 20 mg/kg/day; IP; for 7 and 14 days) reduces the extent of interstitial nephritis and fibrosis (arrowheads) with 10 mg/kg and significantly reduces or absent histopathological changes with 20 mg/kg in unilateral ureteral obstruction (UUO) rats.
?IN-1130 (10, 20 mg/kg/day; for 14 days) dose-dependently decreases levels of TGF-β1 mRNA and suppresses phosphorylation of Smad2, α-SMA, myofibroblasts in rat UUO kidneys.
?IN-1130 (40 mg/kg; IP; 3 times per week for 3 weeks) inhibits in vivo breast cancer metastasis to the lungs in MMTV/c-Neu mice (Eight-week-old female BALB/c mice).
相关产品:Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Kinase Inhibitor Library | TGF-beta/Smad Compound Library | Anti-Cancer Compound Library | Reprogramming Compound Library | Anti-Breast Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Obesity Compound Library | Angiogenesis-Related Compound Library | Transcription Factor-Targeted Library | Targeted Diversity Library | Anti-Colorectal Cancer Compound Library | Human Metabolite Library | Anti-Prostate Cancer Compound Library | Anti-Pulmonary Fibrosis Compound Library | Osteogenesis Compound Library | Cancer Stem Cells Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | Cytokine Inhibitors Library | SB-431542 | Dorsomorphin | A 83-01 | Galunisertib | LDN193189 | RepSox | LY2109761 | DMH-1 | SB 525334 | Vactosertib | BMP signaling agonist sb4 | LY-364947 | SB-505124 | LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA) | GW788388 | ITD-1 | LDN-212854 | LY3200882 | Bimagrumab | ML347 | SD-208 | K02288 | Fresolimumab | LDN-214117 | R-268712
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验, 2650 6. Montminy M R et al 1986 Proc Natl Acad Sci USA 83, 6682 7. Angel P et al 1987 Cell 49, 729 8. Chiu R et al 1988 Cell 54, 541 9. Rauscher F J et al 1988 Cell 52,471 10. Imagawa M et al 1987 Cell 51, 251 11. Berkowitz L A and Gilman M
Quality Control Procedures for Genome‐Wide Association Studies
in combined study populations. PLoS One 5:e9763. Broman, K.W. 1999. Cleaning genotype data. Genet. Epidemiol. 17:S79‐S83.
技术资料暂无技术资料 索取技术资料








![[bAla8]-Neurokinin A(4-10)[bAla8]-神经激肽 A (4-10),122063-01-8](https://img1.dxycdn.com/p/s14/2025/1205/308/0884199279470776991.jpg!wh200)








